Author: admin

U.S.-Africa Chamber of Commerce Appoints Robert Alexander of 360Wise Media as Board Director

U.S.-Africa Chamber of Commerce Appoints Robert Alexander of 360Wise Media as Board Director

“I am honored to join the Board of Directors of the U.S.-Africa Chamber of Commerce,” said Mr. Robert Alexander. “I look forward to working alongside esteemed colleagues such as Dr. Sir Joe Madu, President of the Chamber, and Col. (Rtd) Brian Searcy, Chairman of the Board, to further enhance the Chamber’s impact and promote greater collaboration between Africa and the United States.”
Founded on the principles of promoting economic growth and cultural understanding, the U.S.-Africa Chamber of Commerce serves as a vital conduit for businesses, governments, and individuals seeking to engage in mutually beneficial partnerships. Mr. Alexander’s appointment brings a wealth of experience and expertise in media, branding, and marketing, which will be instrumental in advancing the Chamber’s goals and objectives.

Miami, FL – The U.S.-Africa Chamber of Commerce, a leading organization dedicated to fostering trade, investment, and cultural exchange between Africa and the United States, has appointed Mr. Robert Alexander, CEO/Founder of 360WISE MEDIA, as a member of its Board of Directors. This strategic move underscores the Chamber’s commitment to holistic human and natural capital capacity optimization (H2C2O) and its mission to drive sustainable development and prosperity on both continents.

Founded on the principles of promoting economic growth and cultural understanding, the U.S.-Africa Chamber of Commerce serves as a vital conduit for businesses, governments, and individuals seeking to engage in mutually beneficial partnerships. Mr. Alexander’s appointment brings a wealth of experience and expertise in media, branding, and marketing, which will be instrumental in advancing the Chamber’s goals and objectives.

“I am honored to join the Board of Directors of the U.S.-Africa Chamber of Commerce,” said Mr. Robert Alexander. “I look forward to working alongside esteemed colleagues such as Dr. Sir Joe Madu, President of the Chamber, and Col. (Rtd) Brian Searcy, Chairman of the Board, to further enhance the Chamber’s impact and promote greater collaboration between Africa and the United States.”

Dr. Sir Joe Madu, President of the U.S.-Africa Chamber of Commerce, expressed his enthusiasm for Mr. Alexander’s appointment, stating, “Mr. Alexander’s vast experience in media and communications will be invaluable as we continue to expand our reach and influence. His commitment to excellence and innovation aligns perfectly with our mission, and we are excited to welcome him to the Board.”

Col. (Rtd) Brian Searcy, Chairman of the Board, echoed these sentiments, emphasizing the importance of strategic partnerships in driving economic growth and development. “Mr. Alexander’s appointment underscores our commitment to building bridges between Africa and the United States. His vision and leadership will be instrumental in advancing our shared goals.”

As a member of the Board of Directors, Mr. Robert Alexander will play a key role in shaping the Chamber’s strategic direction and fostering collaboration between businesses, governments, and organizations across Africa and the United States. His appointment marks a significant milestone in the Chamber’s ongoing efforts to promote trade, investment, and cultural exchange between the two continents.

For more information about the U.S.-Africa Chamber of Commerce and its initiatives, please visit www.usafricacoc.com.

Media Contact
Company Name: 360Wise Media
Contact Person: Tasha Alexander
Email: Send Email
Phone: 1-844-360-9473
Address:1200 Brickell Ave suite 1950
City: Miami
State: Florida
Country: United States
Website: https://360Wise.com

Unmatched Flexibility Fuels Market Adoption for Testlio’s Managed Test Automation Solution

25 industry leaders confidently scale their software testing with a comprehensive, AI-powered approach to quality engineering.

Testlio, a global provider of software testing solutions, has announced significant client adoption for its managed test automation solution. The company now provides comprehensive quality engineering capabilities to twenty five digital technology leaders across retail, technology, media, healthcare, and financial services industry verticals. This represents approximately 17% of Testlio’s enterprise-class client base.

Testlio has made recent investments in its test automation solution by launching a dedicated quality engineering (QE) center of excellence, expanding its QE talent, developing a set of standards-based governance methodologies, growing partnerships with industry-leading technology providers, and advancing its artificial intelligence (AI) acumen, including its use of generative AI. The company’s comprehensive approach to managed test automation gives software development teams the freedom to make technology and staffing decisions that are optimized for their current needs without sacrificing their ability to adapt to future market and technology requirements.   

“Managed test automation can be a game changer for engineering leaders searching for a more efficient way to keep pace with test coverage,” said Steve Semelsberger, CEO of Testlio. “Testlio’s offering is designed to help development teams unlock and maintain extraordinary value without being forced to make tradeoffs that can erode ROI over time.” 

Testlio’s approach to managed test automation delivers unmatched flexibility through: 

–  Broad Governance Model. Extended and transferable support for 20+ frameworks, including Cypress, Playwright, Appium, and Selenium, across web, mobile, and other technology platforms, preserves existing automation investments while equipping future migration options.

–  Dynamic Staffing Options. Global, managed teams, powered by a blend of dedicated and on-demand quality engineers, testing managers, quality analysts, and other roles address fluctuating capacity requirements and offer burstable human resources powered by machine learning (ML) algorithms in the Testlio Platform.

–  Unified Run Results. The Testlio Platform also enables unified telemetry and AI-powered run management across potentially disparate runtime environments. Only Testlio provides options for a free proprietary runtime (leveraging a bespoke Testlio Platform integration to the AWS device farm), integrated runtimes (from partners like SauceLabs and BrowserStack), and local device runtimes, per below. 

–  Distributed Device Network. Access to a global network of thousands of locally managed mobile and OTT devices compliments and extends standard cloud coverage options and offers unmatched precision on specific hardware, operating system, and location combinations, powering a new era of in-the-wild automated testing.

–  Robust DevOps Integrations. Pre-built integrations across 20+ CI/CD, test management, issue tracking, and other systems ensure a fluid and seamless managed service experience, regardless of current or future DevOps toolchain choices. 

Testlio guides the test automation journey of industry-leading brands such as athenahealth, Clari, CW Network, Match Group, Microsoft, Quizlet, SAP Concur, Sky, and Strava by delivering unmatched advisory, development, analysis, run management, and other services.

“Testlio has helped us with manual testing for several years,” stated Luke Hargrove, VP of Engineering at athenahealth. “We recently chose them for test automation services as well based on the strength of their integrated quality engineering offering. We’re excited about Testlio’s vision, approach, and capabilities.”

Managed test automation is also extensible to the Testlio Fused Software Testing solution, combining automated and manual testing to directly respond to the tension between quality, speed, and coverage in the software release journey. 

About Testlio

Testlio is a global software testing company. Its unique approach combines humans and machines to help digital innovators assure quality products at scale. On 600K+ real devices. In 100+ languages. With 400+ payment methods. The company is 100% remote, with people in 150+ countries. It is female-founded; 46% of full-time people are women. Clients include Amazon, athenahealth, Match Group, Microsoft, the NBA, Netflix, PayPal, SAP, Uber, Wayfair, and many more. To learn more, visit www.testlio.com.

For media inquiries, please contact Yasmin Mounajed, Testlio VP of Marketing.

Media Contact
Company Name: Testlio
Contact Person: Yasmin Mounajed
Email: Send Email
Country: United States
Website: https://testlio.com

Shiraz Baboo Co-Hosts the 3rd Annual Wealthy Healers Conference

Toronto, Ontario – April 12, 2024 – The Wealthy Healers Conference, founded by Shiraz Baboo is set to empower professional in the healing industry, professionals or coaches who help people improve in the areas of body, mind, or spirit, with essential business acumen. In response to the concerning statistic that many coaches and healers earn less than $35,000 annually, Baboo is on a mission to change that industry statistic forever. The overarching aim of the conference is to equip attendees with the necessary tools and strategies to elevate their businesses to six-figure incomes and beyond.

This groundbreaking event has gathered industry experts to delve into crucial aspects of business often overlooked by coaches and healers, including marketing, sales, automation, public speaking, scaling, publishing, content creation, CRM utilization, effective copywriting, AI integration, and more.

The Wealthy Healers conference is being co-hosted this year by Baboo, and serial entrepreneur Kimberly Crowe. Crowe, the founder of Speakers Playhouse, a platform dedicated to assisting experts with securing speaking engagements, the conference boasts sponsorship from prominent figures in the industry: Rachel Jayne Groover of The Awakened School and Ann Hession of The Soulpreneur Success Code.

“I believe that anyone working to help people improve their mind and body, heal physical and mental trauma, or inspire and train people to achieve big success should be paid well,” said Shiraz Baboo.

Featuring a dynamic lineup of panels, hot seat coaching, workshops, and transformative sessions, the conference promises invaluable insights from numerous speakers who have excelled in building thriving businesses.

Registration: https://mediamastery–energeticmagic.thrivecart.com/wealthy-healers-conference.

About Energetic Magic Inc.

Energetic Magic Inc. provides powerful techniques for business owners to shift not only their mindset but also their business reality. Developed by Shiraz Baboo and based on the premise that our beliefs create our realities, clients have transformed in as little as five minutes and learned to shift their business reality when hitting success barriers. Women executives, entrepreneurs, and coaches ready for a deep and lasting change are invited to discover more at https://www.energeticmagic.com.

Media Contact
Company Name: Vedette Global Media
Contact Person: Angel Tuccy
Email: Send Email
Phone: 720-257-9263
Country: United States
Website: https://vedettenews.com

OG Center: Costa Rica’s Premier Destination for Cutting-Edge Dental Care

OG Center, based in San José, Costa Rica, is transforming dental tourism through advanced technology, cost-effective care, and eco-friendly practices, drawing international patients with high-quality treatments at competitive prices.

Accessing quality dental care in the Western world often comes with a hefty price tag, leaving many individuals needing help with the dilemma of prioritizing their oral health against financial constraints. As dental procedures continue to become increasingly expensive, patients are seeking alternative solutions that offer both affordability and excellence in care. This pressing need has paved the way for the rise of dental tourism, with destinations like OG Center in San José, Costa Rica, emerging as beacons of hope for those in search of high-quality treatments at a fraction of the cost.

OG Center, nestled amidst the scenic landscapes of Costa Rica, presents a compelling proposition for individuals seeking dental implants at an affordable price point. Renowned for its commitment to excellence, cost-effectiveness, and innovative approach, OG Center stands out as a premier destination for those in pursuit of quality dental care without the massive expense typically associated with such procedures.

Foremost among the reasons to consider OG Center for dental implants is its sterling reputation for delivering superior dental care at a fraction of the cost compared to many Western counterparts. Recognizing the prohibitive expenses often associated with dental procedures, OG Center strives to make high-quality dental care accessible to a wider demographic by offering competitive pricing without compromising on quality or service standards.

Moreover, OG Center specializes in catering to the unique needs of international patients seeking dental treatment abroad. The clinic endeavors to ensure a seamless experience for visitors by providing comprehensive support services, including assistance with flight arrangements, local transportation, and round-the-clock customer support. By alleviating the logistical challenges inherent in traveling for medical purposes, OG Center enables patients to focus their energies on their dental health and recovery journey.

What’s more, the success of OG Center lies in its team of highly skilled and experienced dental professionals. With expertise honed in countries like the United States and Germany, the clinic’s dedicated practitioners are adept at devising personalized treatment plans and executing procedures with precision and care. From initial consultation to post-operative care, patients can trust in the expertise and professionalism of the OG Center team every step of the way.

In addition to its human capital, OG Center boasts state-of-the-art facilities and cutting-edge technology to enhance the patient experience and treatment outcomes. Equipped with its own dental laboratory that is outfitted with the latest advancements in dental technology, the clinic is able to deliver top-tier procedures with a focus on patient safety, comfort, and efficacy. Whether it’s digital cosmetic surgery or the innovative All on X technique, OG Center harnesses technology to achieve optimal results and transform smiles effectively and efficiently.

Beyond its commitment to clinical excellence, OG Center distinguishes itself through its unwavering dedication to environmental sustainability. As a proudly Costa Rican company with a decade-long track record, OG Center is deeply committed to minimizing its environmental footprint through the adoption of sustainable practices. From the use of solar panels to water rationalization measures, the clinic is steadfast in its mission to operate in harmony with the environment while delivering exceptional dental care.

Moreover, Costa Rica’s reputation as one of the safest countries in Latin America further enhances OG Center’s appeal as a dental tourism destination. The clinic goes above and beyond to prioritize patient safety and well-being, offering luxury private transportation services to ensure a comfortable and secure experience for patients throughout their dental journey.

Indeed, with its unwavering commitment to excellence, affordability, technological innovation, and environmental sustainability, OG Center offers a compelling proposition for those in search of world-class dental care abroad. By entrusting their dental health to OG Center, patients can embark on a transformative journey that not only enhances their smiles but also safeguards their financial well-being.

Media Contact
Company Name: OG Center Dental
Contact Person: Oscar Guzman
Email: Send Email
Phone: 1-833-smilecr
Country: Costa Rica
Website: https://ogcenter.cr/

Five Tips on How To Get Rich: Vladimir Okhotnikov About the Secret of Success

In a new article Vladimir Okhotnikov of Floralia company, a financial analyst and expert in blockchain, shares his experience.

Vladimir states the fact of a decline in the purchasing power of the population of many developed countries, is caused by a reduction in the money supply due to rising interest rates. The expert points out that one of the best decisions in such difficult times is to choose a new life strategy, the goal of which is to increase our income.

Vladimir calls for a sober assessment of one’s own strengths, and only then relying on them and developing a plan for further action. This is how we understand that allies in the battle for success — are acquired knowledge, skills and abilities.

Vladimir Okhotnikov on how to get rid of fears and start making money

Nothing frightens a businessman more than a loss. However, no one can avoid unsuccessful investments: even the luckiest people lose many millions on individual transactions.

The article shows that the problem lies not so much in the loss of money, but in the lack of determination to change your lifestyle. Many of us in our youth and even adulthood are forced by our parents or all kinds of mentors to choose our appearance, profession, spouse, and lifestyle. Submission to such violence makes people nervous and vulnerable, the analyst concludes.

According to the presented opinion, getting rid of such imposed weakness is the task of anyone who wants to live a full life, which is unthinkable without financial independence. And it cannot be achieved without energy, determination to act and lack of fear.

Passive and active income

Speaking about the advantages and disadvantages of both approaches to investing, the author recalls Robert Kiyosaki with his book “Rich Dad Poor Dad”. According to him, success cannot be achieved without decisive actions:

Vladimir made his first investments in digital assets at the dawn of the Bitcoin era. At that time, few people had heard about blockchain. But the enthusiasm was overwhelming: after all, the new field of activity offered a lot of opportunities.

This case shows: no matter what happened, his admiration for the crypto industry and the world of virtual reality only grew. The result of his efforts were several projects that embodied his ideas about the ideal metaverse.

At the same time, Vladimir advises not to forget about caution, since investing is associated with the threat of losing money.

Time is against us

Vladimir doesn’t see the point of keeping all his money on deposit at a compound interest rate, so that later he can become a millionaire. In this he sees many risks. But the main loss is lost time.

Vladimir recalls that he himself once lost many years working in an office and relying on passive income. He considers the biography of Colonel Sanders, the legendary founder of KFC, to be a true success story. 

“Be like the Colonel: think boldly, don’t waste time, don’t miss a single opportunity. Invest… Swim against the current and you will succeed,” concluded Vladimir Okhotnikov.

Vladimir believes that metaverses are a financial niche that now offers unprecedented opportunities. There is no excitement in this market yet, no crowd. But this silence will not last long. Vladimir warns us about this and much more in his original article entitled “To Pay or Not to Pay: Vladimir Okhotnikov Analyzes Options for Accessing the Metaverse.”

About Company

Floralia company focuses on analytics in IT and crypto business, consulting and project management.  Vladimir Okhotnikov of Floralia is a well-known crypto enthusiast, publicist, and analyst. He is an expert in a number of areas related to the world of investments. In his articles he pays attention to such current topics as the prospects for the DeFi market, and also predicts the future of virtual reality and metaverses.

Media Contact
Company Name: Floralia, LLC
Contact Person: Vladimir Okhotnikov
Email: Send Email
Country: Kazakhstan
Website: https://vladimirokhotnikov.com/

Hidradenitis Suppurativa Market is expected to Grow at a CAGR of 13.5%, estimates DelveInsight

“Hidradenitis Suppurativa Market”
Hidradenitis Suppurativa companies are Inflarx, Novartis Pharmaceuticals, Incyte Corporation, UCB Biopharma, Janssen Pharmaceuticals, Novartis Pharmaceuticals, Amgen, Chemocentryx, Priovant Therapeutics, Pfizer, Anaptysbio, Abbvie, Acelyrin, Aclaris Therapeutics, Boehringer Ingelheim, Eli Lilly, Moonlake Immunotherapeutics, Aristea Therapeutics, among others.

(Albany, USA) DelveInsight’s “Hidradenitis Suppurativa Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of Hidradenitis Suppurativa, historical and forecasted epidemiology as well as the Hidradenitis Suppurativa market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.

The Hidradenitis Suppurativa market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted Hidradenitis Suppurativa market size from 2019 to 2032, segmented by seven major markets. The Report also covers current Hidradenitis Suppurativa treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best opportunities and assesses the underlying potential of the Hidradenitis Suppurativa market.

 

Request for a Free Sample Report @ Hidradenitis Suppurativa Market Forecast

 

Some facts of the Hidradenitis Suppurativa Market Report are:

  • According to DelveInsight, Hidradenitis Suppurativa market size is expected to grow at a decent CAGR by 2032.
  • Leading Hidradenitis Suppurativa companies working in the market are Inflarx, Novartis Pharmaceuticals, Incyte Corporation, UCB Biopharma, Janssen Pharmaceuticals, Novartis Pharmaceuticals, Amgen, Chemocentryx, Priovant Therapeutics, Pfizer, Anaptysbio, Abbvie, Acelyrin, Aclaris Therapeutics, Boehringer Ingelheim, Eli Lilly, Moonlake Immunotherapeutics, Aristea Therapeutics, among others.
  • Key Hidradenitis Suppurativa Therapies expected to launch in the market are HUMIRA, COSENTYX (secukinumab), BIMZELX (bimekizumab), and others.
  • On February 2024, UCB Pharma announced results of a Phase 3, Open-Label, Parallel Group, Multicenter, Extension Study Evaluating the Long-Term Treatment of Bimekizumab in Study Participants With Moderate to Severe Hidradenitis Suppurativa
  • On March 2024, ACELYRIN Inc announced results of a Randomized, Double-blind, Placebo-controlled, Multicenter, Phase 3 Study to Evaluate the Efficacy and Safety of Izokibep in Subjects With Moderate to Severe Hidradenitis Suppurativa.
  • On February 2024, Novartis announced results of a Long Term observAtional, Prospective, Multicenter Study to Collect iN a Real-world populatIon Data on the treatMent Pattern of secukinumAb in Adult Patients With Moderate to Severe Hidradenitis Suppurativa (HS) (ANIMA).
  • On February 2024, Eli Lilly and Company announced results of a Phase 2b, Double-Blind, Placebo-Controlled Study to Evaluate Eltrekibart in Adult Participants With Moderate to Severe Hidradenitis Suppurativa.
  • On March 2024, AbbVie announced a Phase 3, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate Efficacy and Safety of Upadacitinib in Adult and Adolescent Subjects With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-TNF Therapy.

 

Hidradenitis Suppurativa Overview

Hidradenitis suppurativa (HS) is a chronic inflammatory skin condition characterized by painful, recurrent abscesses, nodules, and tunnels in areas rich in apocrine glands, such as the armpits, groin, and buttocks. The exact cause of Hidradenitis suppurativa is not fully understood but likely involves a combination of genetic predisposition, immune dysregulation, and environmental factors. Hidradenitis suppurativa can significantly impact quality of life due to pain, discomfort, and social stigma associated with the visible lesions. Diagnosis is based on clinical presentation and may require histopathological examination to confirm. Hidradenitis suppurativa Treatment strategies aim to alleviate symptoms, prevent new lesions, and improve overall well-being. Options include topical and systemic antibiotics, anti-inflammatory medications, immunosuppressants, biologic therapies, surgical interventions such as drainage and excision, and lifestyle modifications. Multidisciplinary care involving dermatologists, surgeons, and other specialists is often necessary to manage HS effectively and address the diverse needs of affected individuals.

 

Learn more about Hidradenitis Suppurativa treatment algorithms in different geographies, and patient journeys. Contact to receive a sample @ https://www.delveinsight.com/sample-request/hidradenitis-suppurativa-market

 

Hidradenitis Suppurativa Market

The Hidradenitis Suppurativa market outlook of the report helps to build a detailed comprehension of the historical, current, and forecasted Hidradenitis Suppurativa market trends by analyzing the impact of current Hidradenitis Suppurativa therapies on the market and unmet needs, and drivers, barriers, and demand for better technology.

This segment gives a thorough detail of the Hidradenitis Suppurativa market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated Hidradenitis Suppurativa market data are presented with relevant tables and graphs to give a clear view of the market at first sight.

According to DelveInsight, the Hidradenitis Suppurativa market in 7MM is expected to witness a major change in the study period 2019-2032.

The primary approach to treating mild cases of the condition typically involves cleansing with antibacterial solutions and applying topical antibiotics. In instances of sudden exacerbation, healthcare providers may employ corticosteroid injections directly into affected areas and/or minor surgical interventions. For individuals with mild to moderate symptoms, oral treatments may include prolonged courses of broad-spectrum antibiotics and systemic retinoids. Presently, the market largely relies on medications prescribed off-label and HUMIRA, which stands as the sole officially approved therapy for hidradenitis suppurativa thus far.

 

Hidradenitis Suppurativa Epidemiology 

The Hidradenitis Suppurativa epidemiology section provides insights into the historical and current Hidradenitis Suppurativa patient pool and forecasted trends for seven individual major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the Hidradenitis Suppurativa market report also provides the diagnosed patient pool, trends, and assumptions. 

Hidradenitis suppurativa In 2019, the total prevalent cases of Hidradenitis Suppurativa were approximately 2.8 million cases in the US, which is expected to grow during the study period, i.e., 2019–2032.

 

Explore more about Hidradenitis Suppurativa Epidemiology @ Hidradenitis Suppurativa Market Dynamics

 

Hidradenitis Suppurativa Drugs Uptake

This section focuses on the uptake rate of the potential Hidradenitis Suppurativa drugs recently launched in the Hidradenitis Suppurativa market or expected to be launched in 2019-2032. The analysis covers the Hidradenitis Suppurativa market uptake by drugs, patient uptake by therapies, and sales of each drug.

Hidradenitis Suppurativa Drugs Uptake helps in understanding the drugs with the most rapid uptake and the reasons behind the maximal use of new drugs and allows the comparison of the drugs based on Hidradenitis Suppurativa market share and size, which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.

 

Hidradenitis Suppurativa Pipeline Development Activities

The Hidradenitis Suppurativa report provides insights into different therapeutic candidates in Phase II, and Phase III stages. It also analyses Hidradenitis Suppurativa key players involved in developing targeted therapeutics.

 

Request for a sample report to understand more about the Hidradenitis Suppurativa pipeline development activities @ https://www.delveinsight.com/sample-request/hidradenitis-suppurativa-market

 

Hidradenitis Suppurativa Therapeutics Assessment

Major key companies are working proactively in the Hidradenitis Suppurativa Therapeutics market to develop novel therapies which will drive the Hidradenitis Suppurativa treatment markets in the upcoming years are Inflarx, Novartis Pharmaceuticals, Incyte Corporation, UCB Biopharma, Janssen Pharmaceuticals, Novartis Pharmaceuticals, Amgen, Chemocentryx, Priovant Therapeutics, Pfizer, Anaptysbio, Abbvie, Acelyrin, Aclaris Therapeutics, Boehringer Ingelheim, Eli Lilly, Moonlake Immunotherapeutics, Aristea Therapeutics, among others

 

Learn more about the emerging Hidradenitis Suppurativa therapies & key companies @ https://www.delveinsight.com/sample-request/hidradenitis-suppurativa-market

 

Hidradenitis Suppurativa Report Key Insights

1. Hidradenitis Suppurativa Patient Population

2. Hidradenitis Suppurativa Market Size and Trends

3. Key Cross Competition in the Hidradenitis Suppurativa Market

4. Hidradenitis Suppurativa Market Dynamics (Key Drivers and Barriers)

5. Hidradenitis Suppurativa Market Opportunities

6. Hidradenitis Suppurativa Therapeutic Approaches

7. Hidradenitis Suppurativa Pipeline Analysis

8. Hidradenitis Suppurativa Current Treatment Practices/Algorithm

9. Impact of Emerging Therapies on the Hidradenitis Suppurativa Market

 

Table of Contents

1. Key Insights

2. Executive Summary

3. Hidradenitis Suppurativa Competitive Intelligence Analysis

4. Hidradenitis Suppurativa Market Overview at a Glance

5. Hidradenitis Suppurativa Disease Background and Overview

6. Hidradenitis Suppurativa Patient Journey

7. Hidradenitis Suppurativa Epidemiology and Patient Population

8. Hidradenitis Suppurativa Treatment Algorithm, Current Treatment, and Medical Practices

9. Hidradenitis Suppurativa Unmet Needs

10. Key Endpoints of Hidradenitis Suppurativa Treatment

11. Hidradenitis Suppurativa Marketed Products

12. Hidradenitis Suppurativa Emerging Therapies

13. Hidradenitis Suppurativa Seven Major Market Analysis

14. Attribute Analysis

15. Hidradenitis Suppurativa Market Outlook (7 major markets)

16. Hidradenitis Suppurativa Access and Reimbursement Overview

17. KOL Views on the Hidradenitis Suppurativa Market

18. Hidradenitis Suppurativa Market Drivers

19. Hidradenitis Suppurativa Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer

 

About DelveInsight

DelveInsight is a leading Life Science market research and business consulting company recognized for its off-the-shelf syndicated market research reports and customized solutions to firms in the healthcare sector.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: Send Email
Phone: +91-9650213330
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/consulting

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Hidradenitis Suppurativa Market is expected to Grow at a CAGR of 13.5%, estimates DelveInsight

Treatment-Resistant Depression Market to witness growth by 2032, estimates DelveInsight | Navitor Pharmaceuticals, Supernus Pharmaceuti, Novartis, Relmada Therapeutics, COMPASS Pathways, more

“Treatment-Resistant Depression Market”
Treatment-Resistant Depression companies are Navitor Pharmaceuticals, Supernus Pharmaceuti, Novartis, Relmada Therapeutics, Beckley Psytech, COMPASS Pathways, Axsome Therapeutics, Celon Pharma, and several others.

(Albany, USA) DelveInsight’s “Treatment-Resistant Depression Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of Treatment-Resistant Depression, historical and forecasted epidemiology as well as the Treatment-Resistant Depression market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.

The Treatment-Resistant Depression market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted Treatment-Resistant Depression market size from 2019 to 2032, segmented by seven major markets. The Report also covers current Treatment-Resistant Depression treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best opportunities and assesses the underlying potential of the Treatment-Resistant Depression market.

 

Request for a Free Sample Report @ Treatment-Resistant Depression Market Forecast

 

Some facts of the Treatment-Resistant Depression Market Report are:

  • According to DelveInsight, Treatment-Resistant Depression market size is expected to grow at a decent CAGR by 2032.
  • The total Treatment-Resistant Depression market size in the 7MM was approximately ~USD 3,100 million in 2022 and is projected to increase during the forecast period (2023–2032).
  • Leading Treatment-Resistant Depression companies working in the market are Navitor Pharmaceuticals, Supernus Pharmaceuti, Novartis, Relmada Therapeutics, Beckley Psytech, COMPASS Pathways, Axsome Therapeutics, Celon Pharma, and several others.
  • Key Treatment-Resistant Depression Therapies expected to launch in the market are SPRAVATO (esketamine), MIJ821, COMP360 (Psilocybin), and others.
  • On April 2024, COMPASS Pathways announced results of a Phase III, Multicentre, Randomised, Double-blind, Controlled Study to Investigate the Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With Treatment-resistant Depression.
  • On November 2023, Navitor Pharmaceuticals announced results A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of NV-5138 in Adults With Treatment Resistant Depression

 

Treatment-Resistant Depression Overview

Treatment-resistant depression (TRD) refers to a form of major depressive disorder (MDD) that does not respond adequately to standard antidepressant treatments. This condition poses significant challenges to individuals’ well-being and requires specialized management. Treatment-resistant depression may result from various factors, including biological, genetic, psychological, and environmental influences. Symptoms of Treatment-resistant depression often persist despite trials of multiple antidepressant medications and may lead to functional impairment, increased risk of suicide, and reduced quality of life. Treatment approaches for Treatment-resistant depression typically involve a combination of pharmacotherapy, psychotherapy, and adjunctive interventions such as electroconvulsive therapy (ECT), transcranial magnetic stimulation (TMS), or novel emerging treatments like ketamine infusion therapy. Multidisciplinary collaboration between mental health professionals, including psychiatrists, psychologists, and specialized treatment centres, is crucial for assessing individual needs, tailoring treatment plans, and providing ongoing support to enhance outcomes and improve the overall well-being of individuals living with Treatment-resistant depression.

 

Learn more about Treatment-Resistant Depression treatment algorithms in different geographies, and patient journeys. Contact to receive a sample @ https://www.delveinsight.com/sample-request/treatment-resistant-depression-trd-market

 

Treatment-Resistant Depression Market

The Treatment-Resistant Depression market outlook of the report helps to build a detailed comprehension of the historical, current, and forecasted Treatment-Resistant Depression market trends by analyzing the impact of current Treatment-Resistant Depression therapies on the market and unmet needs, and drivers, barriers, and demand for better technology.

This segment gives a thorough detail of the Treatment-Resistant Depression market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated Treatment-Resistant Depression market data are presented with relevant tables and graphs to give a clear view of the market at first sight.

According to DelveInsight, the Treatment-Resistant Depression market in 7MM is expected to witness a major change in the study period 2019-2032.

 

Treatment-Resistant Depression Epidemiology

The Treatment-Resistant Depression epidemiology section provides insights into the historical and current Treatment-Resistant Depression patient pool and forecasted trends for seven individual major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the Treatment-Resistant Depression market report also provides the diagnosed patient pool, trends, and assumptions. 

 

Explore more about Treatment-Resistant Depression Epidemiology @ Treatment-Resistant Depression Market Dynamics

 

Treatment-Resistant Depression Drugs Uptake

This section focuses on the uptake rate of the potential Treatment-Resistant Depression drugs recently launched in the Treatment-Resistant Depression market or expected to be launched in 2019-2032. The analysis covers the Treatment-Resistant Depression market uptake by drugs, patient uptake by therapies, and sales of each drug.

Treatment-Resistant Depression Drugs Uptake helps in understanding the drugs with the most rapid uptake and the reasons behind the maximal use of new drugs and allows the comparison of the drugs based on Treatment-Resistant Depression market share and size, which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.

 

Treatment-Resistant Depression Pipeline Development Activities

The Treatment-Resistant Depression report provides insights into different therapeutic candidates in Phase II, and Phase III stages. It also analyses Treatment-Resistant Depression key players involved in developing targeted therapeutics.

 

Request for a sample report to understand more about the Treatment-Resistant Depression pipeline development activities @ https://www.delveinsight.com/sample-request/treatment-resistant-depression-trd-market

 

Treatment-Resistant Depression Therapeutics Assessment

Major key companies are working proactively in the Treatment-Resistant Depression Therapeutics market to develop novel therapies which will drive the Treatment-Resistant Depression treatment markets in the upcoming years are Navitor Pharmaceuticals, Supernus Pharmaceuti, Novartis, Relmada Therapeutics, Beckley Psytech, COMPASS Pathways, Axsome Therapeutics, Celon Pharma, and several others.

 

Learn more about the emerging Treatment-Resistant Depression therapies & key companies @ https://www.delveinsight.com/sample-request/treatment-resistant-depression-trd-market

 

Treatment-Resistant Depression Report Key Insights

1. Treatment-Resistant Depression Patient Population

2. Treatment-Resistant Depression Market Size and Trends

3. Key Cross Competition in the Treatment-Resistant Depression Market

4. Treatment-Resistant Depression Market Dynamics (Key Drivers and Barriers)

5. Treatment-Resistant Depression Market Opportunities

6. Treatment-Resistant Depression Therapeutic Approaches

7. Treatment-Resistant Depression Pipeline Analysis

8. Treatment-Resistant Depression Current Treatment Practices/Algorithm

9. Impact of Emerging Therapies on the Treatment-Resistant Depression Market

 

Table of Contents

1. Key Insights

2. Executive Summary

3. Treatment-Resistant Depression Competitive Intelligence Analysis

4. Treatment-Resistant Depression Market Overview at a Glance

5. Treatment-Resistant Depression Disease Background and Overview

6. Treatment-Resistant Depression Patient Journey

7. Treatment-Resistant Depression Epidemiology and Patient Population

8. Treatment-Resistant Depression Treatment Algorithm, Current Treatment, and Medical Practices

9. Treatment-Resistant Depression Unmet Needs

10. Key Endpoints of Treatment-Resistant Depression Treatment

11. Treatment-Resistant Depression Marketed Products

12. Treatment-Resistant Depression Emerging Therapies

13. Treatment-Resistant Depression Seven Major Market Analysis

14. Attribute Analysis

15. Treatment-Resistant Depression Market Outlook (7 major markets)

16. Treatment-Resistant Depression Access and Reimbursement Overview

17. KOL Views on the Treatment-Resistant Depression Market

18. Treatment-Resistant Depression Market Drivers

19. Treatment-Resistant Depression Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer

 

About DelveInsight

DelveInsight is a leading Life Science market research and business consulting company recognized for its off-the-shelf syndicated market research reports and customized solutions to firms in the healthcare sector.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: Send Email
Phone: +91-9650213330
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/consulting/conference-coverage-services

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Treatment-Resistant Depression Market to witness growth by 2032, estimates DelveInsight | Navitor Pharmaceuticals, Supernus Pharmaceuti, Novartis, Relmada Therapeutics, COMPASS Pathways, more

RPM Sunstate Provides Key Insights into Investment Success in Florida’s Thriving Market

RPM Sunstate, a leading property management company, focuses on success in the Florida real estate investment market. By understanding the state’s property landscape, RPM Sunstate is the go-to resource for investors seeking to capitalize on Florida’s lucrative opportunities.

Florida’s real estate market interests investors seeking solid returns and steady growth. The Sunshine State offers a variety of investment options, from urban centers to coastal communities. However, this market requires an extensive understanding of local trends, regulations, and investment strategies.

RPM Sunstate’s team of experienced professionals brings decades of collective experience in Florida’s real estate industry. Leveraging their expertise, they have identified key factors contributing to success. From market trends and property valuations to rental demand and regulatory considerations, RPM Sunstate provides investors with comprehensive insights to make informed decisions and maximize investment returns.

Kasey Chang, a satisfied client with RPM Sunstate, said, “RPM Sunstate in Longwood is really a wonderful company. They’ve been managing my 2 properties for about 6 years now and I can honestly say they get better every year. Every member there including Patti, Nikki and Megan are all awesome to work with!! They are always responsive, efficient and proactive with every aspect of managing and leasing out my properties. Thank you RPM Sunstate! I know my properties are in good hands with you all!.” 

Key Insights for Investors

RPM Sunstate emphasizes several pivotal factors investors must consider to succeed in the Florida real estate market. Understanding regional demographic trends is crucial; Florida’s diverse populations and evolving needs can significantly impact market demand. For example, Florida’s major metro areas are booming, with Orlando adding over 54,000 new residents, according to the United States Census Bureau. This rapid growth creates opportunities for investors seeking to capitalize on the state’s thriving real estate market.

Additionally, staying informed about the state’s economy helps investors identify growing areas ideal for investment. Property value appreciation potential is another critical consideration, with some regions offering higher long-term gains than others. According to Florida Realtors, experts anticipate a market ‘reignition’ in the coming months as interest rates stabilize. This presents a compelling opportunity for investors seeking to capitalize on Florida’s thriving real estate market.

Lastly, RPM Sunstate underscores the importance of proactive property management. Effective management preserves the property’s value and ensures steady rental income by keeping tenants satisfied. These insights offer a powerful strategy for investors to secure their stake in Florida’s prospering real estate environment.

Through market research, industry analysis, and hands-on experience, RPM Sunstate offers investors a competitive edge in identifying lucrative investment opportunities and optimizing portfolio performance. Whether clients are seasoned investors or newcomers to the Florida market, RPM Sunstate provides tailored solutions to meet their unique investment objectives.

As Florida’s real estate market evolves, RPM Sunstate remains at the forefront of innovation, continuously refining its strategies and services to deliver value to clients. With a proven track record of success and a dedication to excellence, RPM Sunstate is ready to guide investors and property owners toward financial prosperity in Florida’s thriving real estate market.

About RPM Sunstate:

RPM Sunstate is a full-service property management company that manages single-family and multi-family properties in Palm Beach County, Orlando, and Jacksonville. Committed to excellence and exceptional service, RPM Sunstate helps property owners maximize their investments while providing tenants with outstanding living experiences. RPM Sunstate is dedicated to setting the standard for property management excellence in Florida.

Contact RPM Sunstate today for more information.

Media Contact
Company Name: RPM Sunstate
Contact Person: Marcus Phillips
Email: Send Email
Country: United States
Website: https://www.rpmsunstate.com/

John Kimble’s Path to Purpose: Psych Wards, Prison Dreams, and Personal Training on Label Free Podcast

In this article we highlight Label Free Podcast and host Deanna Radulescu who interviews John Kimble, a former fitness trainer turned life coach. John shares his incredible journey from a life of criminal activity, psych wards, and felonies to finding redemption and purpose. He opens up about his past as a self-proclaimed “gangster” and the events that led him to the psych ward. John also discusses his struggles with alcohol and the impact it had on his mental health.

New Orleans, LA, USA – April 12, 2024 – In a previous episode of the Label Free Podcast, host Deanna Radulescu welcomed guest John Kimble to share his inspiring story of transformation. From a troubled past that led him to psych wards and felonies, John has emerged as a fitness trainer and life coach, dedicated to helping others overcome their own challenges.

The episode delves into John’s journey, starting with his misguided desire to be a gangster and engaging in criminal activities. Despite coming from a good family background, John found himself caught up in a destructive lifestyle that ultimately landed him in a psych ward. Through introspection and intense physical action, John was able to turn his life around and find a new purpose.

Listeners are taken on a raw and emotional journey as John recounts his struggles with addiction, criminal behavior, and thoughts of self-harm. His story serves as a powerful reminder of the resilience of the human spirit and the potential for redemption.

Now, as a fitness trainer and life coach, John focuses on helping others, particularly men dealing with vices and addictions. Through his own experiences, he has developed a unique approach that combines physical fitness with mental and emotional healing.

Deanna Radulescu commends John for his courage and determination in overcoming his past and using his experiences to guide and inspire others. The episode ends with a message of hope and empowerment, encouraging listeners to embrace change and strive for a better future.

To listen to the full episode and learn more about John Kimble’s journey, visit the Label Free Podcast website at http://labelfreepodcast.com or follow John on Instagram at @Kimble_fit. Join Deanna Radulescu for more insightful conversations with dynamic guests on living a label-free life.

Please see direct links to Johns episode below:

Watch: https://www.youtube.com/watch?v=4BIbJJXKSP0&t=23s

Listen: https://podcasts.apple.com/us/podcast/label-free-to-live-your-best-life-live-label-free/id1473450378?i=1000639655246

For media inquiries or interview requests, please contact:

Deanna Radulescu
deanna.kuempel@labelfreepodcast.com
847-902-4885

About Label Free Podcast

The Label Free Podcast, hosted by Deanna Radulescu, is dedicated to promoting acceptance, empowerment, and personal growth. Each episode features engaging conversations with guests who share their unique stories and insights on living a label-free life.

Media Contact
Company Name: Label Free Podcast
Contact Person: Deanna Radulescu
Email: Send Email
Phone: 847-902-4885
Country: United States
Website: https://www.labelfreepodcast.com

Under the Blockchain Boom: The Collaborative Growth with Web3 of SENXAX

In the midst of rapid development in cryptocurrencies and blockchain technology, SENXAX, as an innovative cryptocurrency trading platform, has successfully launched a series of innovative services and applications in the Web3 domain. These mainly focus on decentralized finance (DeFi) and blockchain gaming (GameFi), attracting a large number of new users into the realm of Web3 applications.

 

The team stated that these innovations not only demonstrate the significant progress of SENXAX in technological innovation and market expansion but also make important contributions to enhancing user experience and application diversity. This makes Web3 technology and services more accessible to everyone, further consolidating its leading position in the cryptocurrency industry.

Observing the innovative activities of SENXAX in these areas, particularly in decentralized finance (DeFi), SENXAX has provided users with more efficient and transparent financial experiences by offering innovative financial tools and services, including swap and lending platforms. The introduction of blockchain games (GameFi) and corresponding game tokens has created a new interactive mode by combining gaming entertainment with economic incentives, attracting a large number of gaming enthusiasts and investors. These initiatives have greatly increased user engagement and loyalty.

In the overall development strategy of SENXAX, SENXAX Wallet plays a key role. As a Web3 wallet focused on decentralized exchanges, SENXAX Wallet is committed to supporting various on-chain crypto assets. Marcus, the head of the wallet, revealed that the platform helps users store a wide range of digital assets by providing financial support, exclusive technical resources, and market strategies. Additionally, SENXAX Wallet is dedicated to brand building and policy influence enhancement through collaborations with key partners both within and outside the industry, laying a solid foundation for the legalization, standardization, and broader application of blockchain technology.

Marcus also revealed that SENXAX plans to further deepen its applications in the DeFi and GameFi fields and explore more possibilities using blockchain technology. As Web3 technology continues to mature, SENXAX will continue to serve as an industry pioneer, leading the development and application of blockchain technology. The goal of SENXAX is to become a bridge connecting users, developers, and blockchain technology, driving the prosperity of the entire digital economy. Marcus emphasized that as technology advances and the market matures, the platform is committed to creating a more open, interconnected, and efficient blockchain ecosystem. This will not only promote innovation and popularization of blockchain technology but also bring users more diverse and efficient services.

The collaborative evolution of SENXAX with Web3 is not only a technological breakthrough but also has a profound impact on the entire blockchain industry. As an important partner in this wave, the platform has demonstrated its leading technological strength and deep insights into future trends. In driving the development of the blockchain industry, the platform undoubtedly plays a significant role, with undeniable implications for the future development of the digital economy.

Disclaimer: This press release may contain forward-looking statements. Forward-looking statements describe future expectations, plans, results, or strategies (including product offerings, regulatory plans and business plans) and may change without notice. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements.

Media Contact
Company Name: Senxax Fintech Company
Contact Person: Karan
Email: Send Email
Country: United States
Website: https://www.senxax.org